# WAINUA

NDC: 0310-9400
Generic name: EPLONTERSEN
Labeler / Manufacturer: AstraZeneca Pharmaceuticals LP
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20231221

FDA application: NDA217388

## Active ingredients

- EPLONTERSEN: 45 mg/.8mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0310-9400"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0310-9400
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d7dcb847-71dd-4fff-82d0-d43a465fc096